Breaking News Instant updates and real-time market news.

LULU

Lululemon

$161.63

-0.85 (-0.52%)

06:49
10/02/18
10/02
06:49
10/02/18
06:49

Lululemon price target raised to $185 from $160 at RBC Capital

RBC Capital analyst Brian Tunick raised his price target on Lululemon to $185 and kept his Outperform rating, saying the company is "clearly in the sweetspot of product innovation and consumer engagement". The analyst expects the new management to build on that momentum to help reach its goal of $6B in revenues as it looks to extend its market share growth in North America while also focusing on creating a presence in China. Tunick believes that Lululemon's premium valuation is justified by its "near-term business momentum and open-ended growth story."

LULU Lululemon
$161.63

-0.85 (-0.52%)

09/25/18
DADA
09/25/18
INITIATION
Target $155
DADA
Neutral
Lululemon initiated with a Neutral at DA Davidson
DA Davidson analyst John Morris initiated Lululemon with a Neutral rating and a price target of $155, saying the "quality of its long-term growth rate is not as robust as it has been" even though its forward earnings multiple is near historical highs. The analyst notes that the company's "future growth has higher risk variables associated with the complexity of international expansion across multiple continents and fashion cycle headwinds as the athleisure trend ebbs". Despite the risks, the analyst points to the company's "strong management team and powerful brand equity" in justifying his neutral stance.
09/26/18
09/26/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS UPGRADES IBM TO BUY: UBS analyst John Roy upgraded IBM (IBM) to Buy and raised his price target for the shares to $180 from $160. The market is pricing in a 2% revenue decline, which IBM can beat, Roy believes. Further, his sum-of-the-parts analysis suggests the market is applying virtually no value to IBM's hardware business, which the analyst thinks is "unrealistic." Roy sees a number of additional positives, including operating margin improvement, the Watson hype cycle bottoming this year, and a 4.4% dividend "providing a floor." Shares of IBM were higher by 2% in late morning trading. OPPENHEIMER UPGRADES GOPRO TO OUTPERFORM: Oppenheimer analyst Andrew Uerkwitz upgraded GoPro (GPRO) to Outperform from Perform, with a $9 price target. The analyst believes the company has done everything it can to position itself for success. With compelling features such as live streaming and gimbal-like image stabilization, Uerkwitz called its products are "compelling." This should be enhanced by targeted marketing and a vastly improved software editing suite, he contended. In late morning trading, GoPro shares were higher by 4%. PIPER JAFFRAY BOOSTS ACTIVISION BLIZZARD PRICE TARGET: Piper Jaffray analyst Michael Olson raised his price target for Activision Blizzard (ATVI) to $88 from $84 saying he's increasingly confident in potential for earnings upside in 2018 from "Call of Duty Black Ops 4" and the accompanying Blackout battle royale mode. Both gamer and critical feedback on Blackout have been favorable, Olson said. He believes the Street has underestimated the potential for collective Call of Duty franchise revenue in 2018 and into 2019 and maintained an Overweight rating on shares. UBS CUTS LAM RESEARCH TO NEUTRAL: UBS analyst Tim Arcuri downgraded Lam Research (LRCX) to Neutral from Buy and lowered his price target for the shares to $170 from $220. Arcuri is "stepping to the sidelines" because he sees a big risk for the company in the first half of 2019 due to Lam Research's outsized exposure to Samsung. In late morning trading, shares of Lam Research were lower by almost 2%. DA DAVIDSON STARTS LULULEMON WITH A NEUTRAL: DA Davidson analyst John Morris initiated Lululemon (LULU) with a Neutral rating and a price target of $155, saying the "quality of its long-term growth rate is not as robust as it has been" even though its forward earnings multiple is near historical highs. The analyst noted that the company's "future growth has higher risk variables associated with the complexity of international expansion across multiple continents and fashion cycle headwinds as the athleisure trend ebbs." Despite the risks, the analyst points to the company's "strong management team and powerful brand equity" in justifying his neutral stance.
09/27/18
OPCO
09/27/18
NO CHANGE
Target $190
OPCO
Outperform
Lululemon price target raised to $190 from $180 at Oppenheimer
Oppenheimer analyst Brian Nagel raised his price target for Lululemon to $190 from $180 as he believes the company is now capitalizing meaningfully following a period of significant reinvestment and repositioning, whereby it enhanced merchandising and its digital platform, so as to connect with consumers better online and in stores. The analyst thinks Lululemon represents one of the best omni-channel models in consumer, and reiterates an Outperform rating on the shares.
10/02/18
RILY
10/02/18
NO CHANGE
Target $155
RILY
Neutral
Lululemon price target raised to $155 from $141 at B. Riley FBR
B. Riley FBR analyst Susan Anderson raised her price target for Lululemon to $155 after meeting with the company's new CEO. The analyst keeps a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

NBTB

NBT Bancorp

$36.29

-0.57 (-1.55%)

16:54
10/22/18
10/22
16:54
10/22/18
16:54
Hot Stocks
NBT Bancorp raises quarterly dividend to 26c from 25c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBTB

NBT Bancorp

$36.29

-0.57 (-1.55%)

16:54
10/22/18
10/22
16:54
10/22/18
16:54
Earnings
NBT Bancorp reports Q3 adjusted EPS 68c, consensus 65c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERY

Perry Ellis

$27.50

(0.00%)

16:51
10/22/18
10/22
16:51
10/22/18
16:51
Hot Stocks
Perry Ellis announces completion of its acquisition in $437M transaction »

Perry Ellis International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

FBK

FB Financial

$33.54

-1.36 (-3.90%)

16:51
10/22/18
10/22
16:51
10/22/18
16:51
Earnings
FB Financial reports Q3 adjusted EPS 68c, consensus 72c »

President and Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

FBK

FB Financial

$33.54

-1.36 (-3.90%)

16:49
10/22/18
10/22
16:49
10/22/18
16:49
Hot Stocks
FB Financial authorizes $50M common stock repurchase program »

FB Financial's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

FBK

FB Financial

$33.54

-1.36 (-3.90%)

16:48
10/22/18
10/22
16:48
10/22/18
16:48
Hot Stocks
FB Financial increases quarterly dividend 33% »

FB Financial Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

SSB

South State

$73.05

-1.975 (-2.63%)

16:48
10/22/18
10/22
16:48
10/22/18
16:48
Earnings
South State reports Q3 adjusted EPS $1.33, consensus $1.40 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVE

Universal Insurance

$47.72

0.72 (1.53%)

16:47
10/22/18
10/22
16:47
10/22/18
16:47
Hot Stocks
Universal Insurance announces expected financial impact from weather events »

Universal Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

HLT

Hilton

$70.17

-0.49 (-0.69%)

16:47
10/22/18
10/22
16:47
10/22/18
16:47
Initiation
Hilton initiated  »

Hilton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

SENS

Senseonics

$3.47

-0.14 (-3.88%)

16:46
10/22/18
10/22
16:46
10/22/18
16:46
Hot Stocks
Senseonics announces Aetna's positive coverage decision for Eversense »

Senseonics Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

CEMI

Chembio Diagnostics

$9.68

-0.05 (-0.51%)

16:44
10/22/18
10/22
16:44
10/22/18
16:44
Hot Stocks
Chembio Diagnostics acquires opTricon GmbH for $5.5M in cash »

Chembioannounced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

HLT

Hilton

$70.17

-0.49 (-0.69%)

16:43
10/22/18
10/22
16:43
10/22/18
16:43
Initiation
Hilton initiated  »

Hilton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

H

Hyatt

$69.50

-0.18 (-0.26%)

16:43
10/22/18
10/22
16:43
10/22/18
16:43
Initiation
Hyatt initiated  »

Hyatt initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

MAR

Marriott

$111.49

-0.58 (-0.52%)

16:42
10/22/18
10/22
16:42
10/22/18
16:42
Initiation
Marriott initiated  »

Marriott initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CEMI

Chembio Diagnostics

$9.68

-0.05 (-0.51%)

16:41
10/22/18
10/22
16:41
10/22/18
16:41
Earnings
Chembio Diagnostics sees Q3 revenue $9.2M-$9.5M, two estimate consensus $8.05M »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

CIEN

Ciena

$30.97

0.23 (0.75%)

16:41
10/22/18
10/22
16:41
10/22/18
16:41
Initiation
Ciena initiated  »

Ciena resumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSTM

HealthStream

$28.30

0.39 (1.40%)

16:40
10/22/18
10/22
16:40
10/22/18
16:40
Earnings
HealthStream sees FY18 revenue growth of 6%-8%, consensus $229.26M »

"Consistent with our…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HSTM

HealthStream

$28.30

0.39 (1.40%)

16:38
10/22/18
10/22
16:38
10/22/18
16:38
Hot Stocks
HealthStream CFO Gerard Hayden, Jr. resigns, Scott Roberts named interim CFO »

HealthStream's CFO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

AFMD

Affimed N.V.

$3.15

-0.06 (-1.87%)

16:38
10/22/18
10/22
16:38
10/22/18
16:38
Syndicate
Breaking Syndicate news story on Affimed N.V. »

Affimed N.V. files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$102.58

-0.48 (-0.47%)

16:37
10/22/18
10/22
16:37
10/22/18
16:37
Hot Stocks
ResMed says it won German patent infringement case against Fisher & Paykel »

ResMed announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

FN

Fabrinet

$44.71

-0.3 (-0.67%)

16:36
10/22/18
10/22
16:36
10/22/18
16:36
Initiation
Fabrinet initiated  »

Fabrinet resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

Wex

$186.64

0.47 (0.25%)

16:36
10/22/18
10/22
16:36
10/22/18
16:36
Hot Stocks
Wex signs agreement to acquire Noventis »

WEX announced the signing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 26

    Nov

GOOG

Alphabet

$1,100.52

4.11 (0.37%)

16:36
10/22/18
10/22
16:36
10/22/18
16:36
Hot Stocks
Google's YouTube investing $20M in education resources for 'EduTubers' »

YouTube is investing $20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

HSTM

HealthStream

$28.30

0.39 (1.40%)

16:36
10/22/18
10/22
16:36
10/22/18
16:36
Earnings
HealthStream reports Q3 EPS 9c, consensus 8c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WASH

Washington Trust

$52.03

-1.25 (-2.35%)

16:36
10/22/18
10/22
16:36
10/22/18
16:36
Earnings
Washington Trust reports Q3 EPS $1.01, consensus 98c »

"Washington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.